NEW DELHI, April 7 - India has decided to partially lift a ban on export of anti-malarial drug hydroxychloroquine, paving the way for its supply to the US and several other countries hit hard by the coronavirus pandemic.
Government officials said India would export hydroxychloroquine and paracetamol on a case-by-case basis to the countries which have already placed orders for them after meeting the domestic requirements.
The decision to partially lift the ban on hydroxychloroquine came to the fore hours after US President Donald Trump warned of retaliation if India does not heed to his request to supply the drug, cited by him as a viable therapeutic solution to fight coronavirus infection.
In a telephonic conversation with Prime Minister Narendra Modi on Sunday, Trump sought supply of hydroxychloroquine (HCQ) to the US.
�In view of the humanitarian aspects of the pandemic, it has been decided that India would licence paracetamol and HCQ in appropriate quantities to all our neighbouring countries who are dependent on our capabilities,� said MEA spokesperson Anurag Srivastava. � PTI
